The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamamoto, N.
Right arrow Articles by Popoff, S. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamamoto, N.
Right arrow Articles by Popoff, S. N.

The Journal of Immunology, Vol 152, Issue 10 5100-5107, Copyright © 1994 by American Association of Immunologists

ARTICLES

A defect in the inflammation-primed macrophage-activation cascade in osteopetrotic rats

N Yamamoto, DD Lindsay, VR Naraparaju, RA Ireland and SN Popoff
Department of Biochemistry, Temple University School of Medicine, Philadelphia, PA 19140.

Macrophages were activated by administration of lysophosphatidylcholine (lyso-Pc) or dodecylglycerol (DDG) to wild-type rats but not in osteopetrotic (op) mutant rats. In vitro treatment of wild-type rat peritoneal cells with lyso-Pc or DDG efficiently activated macrophages whereas treatment of op mutant rat peritoneal cells with lyso-Pc or DDG did not activate macrophages. The inflammation-primed macrophage activation cascade in rats requires participation of B lymphocytes and vitamin D binding protein (DBP). Lyso-Pc-inducible beta-galactosidase of wild-type rat B lymphocytes can convert DBP to the macrophage- activating factor (MAF), whereas B lymphocytes of the op mutant rats were shown to be deficient in lyso-Pc-inducible beta-galactosidase. DBP is conserved among mammalian species. Treatment of human DBP (Gc1 protein) with commercial glycosidases yields an extremely high titrated MAF as assayed on mouse and rat macrophages. Because the enzymatically generated MAF (GcMAF) bypasses the role of lymphocytes in macrophage activation, the op mutant rat macrophages were efficiently activated by administration of a small quantity (100 pg/rat) of GcMAF. Likewise, in vitro treatment of op rat peritoneal cells with as little as 40 pg GcMAF/ml activated macrophages.


This article has been cited by other articles:


Home page
 Clin. Chem.Home page
R. M. Kanan, D. B. Cook, and H. K. Datta
Lectin Immunoassay for Macrophage-activating Factor (Gc-MAF) Produced by Deglycosylation of Gc-Globulin: Evidence for Noninducible Generation of Gc-MAF
Clin. Chem., March 1, 2000; 46(3): 412 - 414.
[Full Text] [PDF]

Home page
 BloodHome page
H. K. Datta, D. B. Cook, R. M. Kanan, A. R. Gennery, and A. J. Cant
Evidence for Continuous Basal Generation of Gc-MAF: Absence in Infantile Osteopetrosis and Restoration After Bone Marrow Transplant
Blood, June 1, 1999; 93(11): 4026 - 4027.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1994 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1994 by The American Association of Immunologists, Inc. All rights reserved.